Attenuation of MODS-related and ARDS-related mortality makes infectious complications a remaining challenge in the

Karlijn J P van Wessem1, Falco Hietbrink1, Luke P H Leenen1

  • 1Department of Trauma Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Abstract

Insights

Infectious complications affect nearly half of polytrauma patients, increasing hospital resource use without raising mortality. Infections remain a key challenge in severe trauma care.

Area of Science:

  • Trauma Surgery
  • Critical Care Medicine
  • Infectious Diseases

Background:

  • Advances in trauma care have reduced mortality from multiple organ dysfunction syndrome (MODS) and adult respiratory distress syndrome (ARDS).
  • However, infections remain a significant challenge in polytrauma patients, contributing to high morbidity and resource utilization.
  • This study aimed to determine the current incidence of infectious complications in this patient population.

Purpose of the Study:

  • To investigate the incidence and characteristics of infectious complications in severely injured polytrauma patients.
  • To identify factors associated with the development of infections post-trauma.
  • To assess the impact of infections on patient outcomes and hospital resource consumption.

Main Methods:

  • A prospective, population-based cohort study was conducted over 5.5 years.
  • Included were severely injured patients (age >15) admitted to a Level-1 trauma center ICU who survived >48 hours.
  • Data collected included demographics, injury severity, physiological parameters, organ failure scores, and specific infectious complications.

Main Results:

  • 45% of 297 polytrauma patients developed infectious complications, with pneumonia being the most frequent (50%).
  • Patients with infections had higher rates of MODS, required longer ventilation and ICU stays, and consumed more hospital resources.
  • Despite increased resource use and MODS, infectious complications did not significantly impact overall mortality rates.

Conclusions:

  • Infectious complications are highly prevalent in polytrauma patients, presenting a significant challenge.
  • While not increasing mortality, infections substantially elevate morbidity and hospital resource utilization.
  • Addressing infectious complications is crucial for improving outcomes and managing resources in severe trauma care.

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
377
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
714
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
928
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
671
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
677